recipharm advanced bio

Private

Last Round

Take Private

Feb 15, 2021

Last Round Size

$2.28B

Est. Valuation

$3B

Total Funding Raised

$2.82B

Company Overview

A contract development and manufacturing organization (CDMO) focused on advanced therapy medicinal products (ATMPs).

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Compare recipharm advanced bio with similar companies based on industry and business-model similarity.

No public comparables are available for recipharm advanced bio. Request access to learn about comparables coverage.

Historical fundraising activity

Explore SEC and related filing metadata, where available.

recipharm advanced bio filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Headquarters—

Year Founded2022

Last FundingFeb 15, 2021

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?